SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 30th, 2024 • Monopar Therapeutics • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 28, 2024, between Monopar Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 18th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ______________, 2024, between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 5th, 2024 • Oragenics Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 5th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September [__], 2024, between Oragenics, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 13th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ______________, 2024, between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 27th, 2024 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 24th, 2024 (the “Effective Date”), between Aridis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
Securities Purchase AgreementSecurities Purchase Agreement • May 17th, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 14, 2024, between BriaCell Therapeutics Corp., a corporation existing under the Business Corporations Act of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 7th, 2024 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 7th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 1, 2024, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 1st, 2024 • Inspira Technologies OXY B.H.N. LTD • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 1st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2024, between Inspira Technologies OXY B.H.N. Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 20th, 2024 • Genprex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 20th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 19, 2024, between Genprex, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 12th, 2024 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJanuary 12th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2024, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 21st, 2023 • Bynd Cannasoft Enterprises Inc. • Services-prepackaged software • New York
Contract Type FiledDecember 21st, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 19, 2023, between BYND Cannasoft Enterprises Inc., a Canada corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 16th, 2023 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 16th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 16, 2023, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 16th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledOctober 16th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 12, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 4th, 2023 • ReTo Eco-Solutions, Inc. • Abrasive, asbestos & misc nonmetallic mineral prods • New York
Contract Type FiledOctober 4th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ____ ____, 2023, between ReTo Eco-Solutions, Inc., a British Virgin Islands business company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 27th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 21, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 18th, 2023 • Athersys, Inc / New • Pharmaceutical preparations • New York
Contract Type FiledAugust 18th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 17, 2023, between Athersys, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 7th, 2023 • Athersys, Inc / New • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of [●], 2023, between Athersys, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 31st, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJuly 31st, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 31, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2023 • Athersys, Inc / New • Pharmaceutical preparations • New York
Contract Type FiledJuly 26th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of [●], 2023, between Athersys, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 12th, 2023 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 12th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _______, 2023, between Galmed Pharmaceuticals, a company incorporated under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing...Securities Purchase Agreement • July 6th, 2023 • Curis Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 6th, 2023 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2023 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJune 28th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _______, 2023, between Galmed Pharmaceuticals, a company incorporated under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 12th, 2023 • Sunworks, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
Contract Type FiledJune 12th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 8, 2023, between Sunworks, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 25th, 2023 • Achieve Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 25th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 25, 2023, between Achieve Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2023 • ReTo Eco-Solutions, Inc. • Abrasive, asbestos & misc nonmetallic mineral prods • New York
Contract Type FiledMay 19th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ____ ____, 2023, between ReTo Eco-Solutions, Inc., a British Virgin Islands business company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 15th, 2023 • Upexi, Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledMay 15th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 11, 2023, between Upexi, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2023 • HeartBeam, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 5th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2023, between HeartBeam Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2023 • U.S. Gold Corp. • Metal mining • New York
Contract Type FiledApril 10th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 4, 2023 and is between U.S. Gold Corp., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2023 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 30, 2023, between Akari Therapeutics, Plc, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 24th, 2023 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 24th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 23, 2023 (the “Effective Date”), between Adial Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 13th, 2023 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 9, 2023, between Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2023 • MediWound Ltd. • Medicinal chemicals & botanical products • New York
Contract Type FiledFebruary 7th, 2023 Company Industry JurisdictionThis securities purchase agreement (this “Agreement”) is dated as of February 3, 2023, between MediWound Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages attached hereto (each, including its successors and assignees, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 30th, 2023 • E-Home Household Service Holdings LTD • Services-miscellaneous repair services • New York
Contract Type FiledJanuary 30th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2023, between E-Home Household Service Holdings Limited, a Cayman Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 24th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJanuary 24th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 23, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2022 • E-Home Household Service Holdings LTD • Services-miscellaneous repair services • New York
Contract Type FiledNovember 21st, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 18, 2022, between E-Home Household Service Holdings Limited, a Cayman Islands company (the “Company”), and ________________ (the “Purchaser”).